JZN48685

• CAT Number: I029931
• CAS Number: 26348-68-5
• Molecular Formula: C15H23ClN2O4
• Molecular Weight: 330.81
• Purity: 98%
• Synonyms: JZN48685; JZN 48685; JZN-48685; Z-Lys-OMe (hydrochloride); Z-Lys-OMe hydrochloride; Z-Lys-OMe HCl
• Solubility: To be determined
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: methyl (2S)-6-amino-2-(phenylmethoxycarbonylamino)hexanoate;hydrochloride
• InChI: InChI=1S/C15H22N2O4.ClH/c1-20-14(18)13(9-5-6-10-16)17-15(19)21-11-12-7-3-2-4-8-12;/h2-4,7-8,13H,5-6,9-11,16H2,1H3,(H,17,19);1H/t13-;/m0./s1
• InChIKey: JRPJBBBQIKFKEB-ZOWNYOTGSA-N
• SMILES: COC(=O)[C@H](CCCCN)NC(=O)OCC1=CC=CC=C1.Cl

JZN48685（Cat No.:I029931）is an experimental drug under investigation for its potential therapeutic applications in oncology and immunology. It is a small molecule designed to modulate specific cellular pathways, targeting cancer cells and potentially enhancing immune responses. The drug works by inhibiting key proteins involved in tumor growth and immune evasion, making it a promising candidate for cancer treatment. Currently in preclinical or early clinical development, JZN48685’s efficacy and safety profile are being evaluated. As with all investigational drugs, it is important to monitor for side effects during clinical trials.